Choksi Laboratories Ltd.

BSE: CHOKSILA526546ISIN INE493D01013

Healthcare
Healthcare Service Provider

BSE listing

Share price

₹198.05-3.40 (-1.69%)

as of 18 Sep 2026

52W high: ₹216.95
52W low: ₹81.85
Off 52W high: -8.71%
1M return: +45.73%
3M return: +61.08%
6M return: +77.07%
1Y return: -1.07%
20D avg volume: 29,974
50 DMA: ₹137.67
200 DMA: ₹120.01

Key ratios Standalone

Market cap: ₹137.95 Cr
Current price: ₹198.05
52W high / low: ₹216.95 / ₹81.85
Face value: ₹10.00
P/E: 63.89
P/B: 5.99
EPS (TTM): ₹3.10
Book value / share: ₹33.06
ROE: 9.39%
ROCE: 12.30%
Operating margin: 27.36%
Net margin: 4.82%
Debt / equity: 1.18
Net debt: ₹29.97 Cr
Interest cover: 2.13
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 74.4 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	12.06	12.82	10.82	11.12	11.24	11.40	—
	0.02	0.06	0.13	0.01	0.00	0.04	—
	11.48	11.78	10.83	10.57	10.62	10.18	—
	0.81	1.01	0.88	0.71	0.84	0.80	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	4.88	4.91	4.54	4.57	4.59	4.52	—
	0.73	0.71	0.81	0.69	0.60	0.58	—
	1.97	1.89	1.83	1.69	1.68	1.70	—
	3.08	3.26	2.77	2.91	2.90	2.58	—
	0.60	1.10	0.13	0.56	0.63	1.26	—
	0.00	0.00	0.78	0.00	0.00	0.00	—
	0.60	1.10	0.90	0.56	0.63	1.26	—
	0.02	0.07	0.59	0.32	0.24	0.34	—
	0.58	1.03	0.31	0.24	0.39	0.92	—
	0.84	1.47	0.45	0.35	0.55	1.32	—
Key metrics
	3.30	3.70	3.54	2.94	2.91	3.54	—
	27.40%	28.90%	32.70%	26.40%	25.90%	31.10%	—
	4.80%	8.00%	2.90%	2.20%	3.50%	8.10%	—
	—	3.70%	—	3.00%	—	4.40%	—
	7.30%	12.50%	—	—	—	—	—
	48.70%	12.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	46.82	46.01	41.78	—
	0.22	0.21	0.07	—
	44.66	43.78	39.70	—
	3.41	3.44	3.10	—
	0.00	0.00	0.00	—
	18.90	18.62	16.98	—
	2.94	2.82	2.65	—
	7.38	7.09	6.50	—
	12.02	11.81	10.47	—
	2.39	2.44	2.15	—
	0.78	0.75	0.00	—
	3.16	3.19	2.15	—
	1.00	1.23	0.63	—
	2.16	1.96	1.52	—
	3.11	2.82	2.19	—
Key metrics
	13.48	13.10	11.30	—
	28.79%	28.50%	27.00%	—
	4.61%	4.30%	3.60%	—
	—	12.30%	11.60%	—
	—	10.10%	—	—
	—	28.90%	—	—
	—	1.03	4.34	—
	—	4.39	7.75	—
	—	1.18	1.19	—
	—	29.97	27.46	—
	—	74.4	56.0	—
Balance sheet
	—	71.92	65.33	—
	—	18.87	16.32	—
	—	0.21	0.61	—
	—	14.73	11.27	—
	—	0.24	0.56	—
	—	0.90	0.68	—
	—	47.42	46.35	—
	—	5.60	5.43	—
	—	23.09	23.88	—
	—	30.18	28.07	—
	—	12.37	12.84	—
	—	17.81	15.23	—
	—	25.58	23.60	—
Cash flow
	—	8.61	11.78	—
	—	-7.82	-7.62	—
	—	-1.20	-4.20	—
	—	7.58	7.44	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Filings & corporate actions

Recent announcements

Board of Director in the board meeting dated 19.09.2026 has approved the issuance and allotment of warrants convertible into shares to promoter subject to approval from shareholders.19 Sep 2026 · Company Update / General
The voting result along with scrutinizer report for the AGM held on 18.09.202619 Sep 2026 · AGM/EGM / AGM
1. Issuance and allotment of upto 3,50,000 (Three Lakh Fifty Thousand) warrants, fully convertible into one fully paid-up equity share of the Company to the Persons belonging to Promoter ....19 Sep 2026 · Board Meeting / Outcome of Board Meeting
Proceedings of the 33rd Annual General Meeting held on 18.09.202618 Sep 2026 · AGM/EGM / AGM
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2026 ,inter alia, to consider and approve 1. To consider and approve ....14 Sep 2026 · Board Meeting / Board Meeting
Submission of newspaper clipping for the Notice of 33rd Annual General Meeting of the company27 Aug 2026 · Company Update / Newspaper Publication
Submission of intimation for dispatch of letter regarding notice of upcoming AGM to those shareholders whose email addresses are not registered with the company/RTA or depositories27 Aug 2026 · Company Update / General
Submission of Annual Report for the F.Y. 2025-2625 Aug 2026 · Others / Reg. 34 (1) Annual Report
Submission of Notice convening 33rd AGM of the company to be held on 18th September, 2026 at 12:30 p.m. through Video conference/Other Audio Visual means25 Aug 2026 · AGM/EGM / AGM
Intimation under Regulation 30 of SEBI (LODR) 2015 for inspection of USFDA21 Aug 2026 · Company Update / General
Submission of newspaper clipping of information regarding 33rd Annual General Meeting of the company21 Aug 2026 · Company Update / Newspaper Publication
Newspaper publication of unaudited financial result for the quarter ended 30th June, 202614 Aug 2026 · Company Update / Newspaper Publication
Reappointment of Internal Auditor for the F.Y. 2026-2713 Aug 2026 · Company Update / Change in Management
Reappointment of Ms. Himika Choksi as Whole Time Director for further period of five year w.e.f 01.04.2027 subject to approval from shareholders in the ensuing AGM.13 Aug 2026 · Company Update / Change in Management
Considered and approved the unaudited financial results of the company for the quarter ended 30th June. 202613 Aug 2026 · Result / Financial Results
1. Considered and approved the Unaudited Financial Results for the Quarter ended on 30th June, 2026 along with the Limited review report; 2. Decided the date for closure of Register of ....13 Aug 2026 · Board Meeting / Outcome of Board Meeting
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. To consider and approve ....5 Aug 2026 · Board Meeting / Board Meeting
Newspaper publication of information regarding change of RTA4 Aug 2026 · Company Update / Newspaper Publication
Intimation for change of RTA in pursuant to Regulation 30 of SEBI (LODR) 20153 Aug 2026 · Company Update / Allotment of Warrants
Submission of Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 20186 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation for Closure of trading window w.e.f. 01st July, 202626 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Submission of newspaper publication of financial result for the period ended 31.03.202626 May 2026 · Company Update / Newspaper Publication
Submission of Annual Secretarial Compliance report under Regulation 24A issued by M/s Surabhi Agrawal & Associate for the year ended 31.03.202625 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Result as attached25 May 2026 · Result / Financial Results
1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March, 2026 along with the along with the Auditors Report thereon, Statement of Assets ....25 May 2026 · Board Meeting / Outcome of Board Meeting
The clarification has been attached herewith in pursuant to additional details required for the corporate announcement filed under Regulation 3019 May 2026 · Company Update / General
Intimation for appointment of Mrs. Stela Choksi as Chief Financial Officer of the company18 May 2026 · Company Update / Change in Management
Intimation for resignation of Mr. Vyangesh Choksi as Chief Financial Officer of the company18 May 2026 · Company Update / Resignation of Chief Financial Officer (CFO)
1. Considered and reviewed for purchasing of 1 MG Windsor car in the name of company along with loan facilities from HDFC bank. 2. Discussed and approved for initiating the process of ....18 May 2026 · Board Meeting / Outcome of Board Meeting
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve 1.To consider and approve ....16 May 2026 · Board Meeting / Board Meeting
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve 1.To consider and approve ....13 May 2026 · Board Meeting / Board Meeting
Submission of scrutinizer report along with voting result of e-voting done by shareholder by means of postal ballot28 Apr 2026 · AGM/EGM / Postal Ballot
Submission of Voting result along with Scrutinizer report of e-voting done by shareholders of the company by means of postal ballot28 Apr 2026 · AGM/EGM / Postal Ballot
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....15 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Submission of Certificate issued by RTA under Regulation 74(5) of SEBI (DP) Regulations, 20187 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation for newspaper publication of information related to Postal ballot notice and e-voting process27 Mar 2026 · Company Update / Newspaper Publication
Intimation for closure of trading window w.e.f. 01.04.202626 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation for postal ballot notice26 Mar 2026 · AGM/EGM / Postal Ballot
Submission of published unaudited financial result for the quarter and nine month ended 31.12.2025 in the newspaper9 Feb 2026 · Company Update / Newspaper Publication
Intimation of Reconstitution of committees of board of directors7 Feb 2026 · Company Update / General

Board meetings

13 Aug 2026 Board Meeting - Financial Results